Atlas Trials

Doxil and Gemcitabine in Recurrent Ovarian Cancer

Clinical trial NCT00312650 · TERMINATED

Trial details

NCT number
NCT00312650
Sponsor
Women and Infants Hospital of Rhode Island
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Carcinoma
Start date
2006-04-01
Primary completion
2006-05-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.